Schroder Investment Management Group’s Tandem Diabetes Care TNDM Stock Holding History

Schroder Investment Management Group’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-37,242	Closed	-$2.24M	–	1348
2022 Q2	$2.24M	Sell	37,242 -64,026	-63%	-$5.26M	﹤0.01%	945
2022 Q1	$11.8M	Buy	101,268 +41,015	+68%	+$4.79M	0.02%	635
2021 Q4	$9.07M	Buy	60,253 +3,346	+6%	+$452K	0.01%	625
2021 Q3	$6.79M	Buy	56,907 +4,100	+8%	+$452K	0.01%	708
2021 Q2	$5.14M	Buy	+52,807	New	+$4.71M	0.01%	822
2020 Q1	–	Sell	-2,371	Closed	-$141K	–	1391
2019 Q4	$141K	Buy	+2,371	New	+$146K	﹤0.01%	1185
2014 Q1	–	Sell	-11,090	Closed	-$2.86M	–	1513
2013 Q4	$2.86M	Buy	+11,090	New	+$2.54M	﹤0.01%	887

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Schroder Investment Management Group's TNDM Position: Q3 2022 in Review

Schroder Investment Management Group sold out of Tandem Diabetes Care (TNDM) in Q3 2022, closing a stake of 37,242 shares — an estimated $2.24M sold.

Schroder Investment Management Group first reported a position in TNDM in Q4 2013 and held it in 7 quarters. The position peaked at $11.8M in Q1 2022. 299 funds tracked by Wall St. Rank hold TNDM as of Q3 2022.

Schroder Investment Management Group reported no remaining Tandem Diabetes Care position as of Q3 2022 after selling out during the quarter.
Schroder Investment Management Group sold 37,242 Tandem Diabetes Care shares in Q3 2022, an estimated $2.24M.
Schroder Investment Management Group first reported a position in Tandem Diabetes Care in Q4 2013 and held it in 7 quarters.
Schroder Investment Management Group's Tandem Diabetes Care position peaked at $11.8M in Q1 2022.
299 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2022.

Based on Schroder Investment Management Group's 13F filing for Q3 2022, filed 14 Nov 2022.